Advertisement

Pfizer Inc. PFE

Set alert

Price alert · PFE

All alert types
30.52 USD +0.57 +1.90%

At close · Oct 30

30.45 -0.07 -0.22%

After hours · Oct 30, 7:55 PM ET

Bid
30.50 × 16,800
Ask
30.52 × 4,900
30.14 Day range 30.65
23.67 52-week range 30.52
YTD
+22.57%
1 year
+25.65%
Open
30.51
Prev close
29.95
Mkt cap
173.95B
Vol
45.49M
Avg vol
33.75M
EPS
0.76
P/E
40.16
Div yield
5.74%
More statistics
Low
30.14
High
30.65
Forward P/E
10.58
Beta
0.28
Short ratio
4.20
Inst. own
69.06%
Dividend
1.72
Ex-div date
Nov 5, 2026
Earnings
Nov 3, 2026
50-d avg
28.49
200-d avg
26.77
1y target
29.26

5D chart

Chart tools
Interval

Signals (88)
NameTimeAgo
MACD: Buy SignalOct 30, 3:50 PM1 day ago
SMA: BullishOct 30, 3:45 PM1 day ago
SMA: BearishOct 30, 3:40 PM1 day ago
SMA: BullishOct 30, 3:30 PM1 day ago
SMA: BearishOct 30, 2:30 PM1 day ago
SMA: BearishOct 30, 2:15 PM1 day ago
SMA: BullishOct 30, 1:30 PM1 day ago
MACD: Sell SignalOct 30, 12:55 PM1 day ago
RSI: OverboughtOct 30, 12:40 PM1 day ago
MACD: Buy SignalOct 30, 12:20 PM1 day ago
SMA: BullishOct 30, 12:05 PM1 day ago
SMA: BearishOct 30, 11:45 AM1 day ago
SMA: BullishOct 30, 10:50 AM1 day ago
MACD: Sell SignalOct 30, 10:20 AM1 day ago
RSI: OverboughtOct 30, 10:10 AM1 day ago
SMA: BearishOct 30, 10:05 AM1 day ago
RSI: OverboughtOct 29, 3:15 PM2 days ago
MACD: Buy SignalOct 29, 2:30 PM2 days ago
SMA: BullishOct 29, 2:20 PM2 days ago
SMA: BearishOct 29, 1:20 PM2 days ago
SMA: BullishOct 29, 1:15 PM2 days ago
SMA: BearishOct 29, 1:10 PM2 days ago
SMA: BullishOct 29, 12:55 PM2 days ago
SMA: BearishOct 29, 11:50 AM2 days ago
SMA: BearishOct 29, 11:30 AM2 days ago
SMA: BullishOct 29, 10:40 AM2 days ago
MACD: Sell SignalOct 29, 10:15 AM2 days ago
SMA: BearishOct 29, 10:05 AM2 days ago
RSI: OverboughtOct 29, 9:50 AM2 days ago
RSI: OverboughtOct 29, 9:30 AM2 days ago
SMA: BullishOct 28, 3:15 PM3 days ago
SMA: BearishOct 28, 3:10 PM3 days ago
SMA: BullishOct 28, 3:05 PM3 days ago
SMA: BearishOct 28, 2:15 PM3 days ago
SMA: BullishOct 28, 2:05 PM3 days ago
SMA: BearishOct 28, 2:00 PM3 days ago
SMA: BullishOct 28, 1:20 PM3 days ago
MACD: Buy SignalOct 28, 1:15 PM3 days ago
RSI: OversoldOct 28, 1:15 PM3 days ago
RSI: OversoldOct 28, 12:15 PM3 days ago
RSI: OversoldOct 28, 12:00 PM3 days ago
SMA: BearishOct 28, 11:00 AM3 days ago
SMA: BearishOct 28, 11:00 AM3 days ago
MACD: Sell SignalOct 28, 11:00 AM3 days ago
SMA: BullishOct 28, 10:55 AM3 days ago
MACD: Buy SignalOct 28, 10:55 AM3 days ago
SMA: BearishOct 28, 10:10 AM3 days ago
SMA: BearishOct 28, 10:10 AM3 days ago
MACD: Sell SignalOct 28, 10:10 AM3 days ago
MACD: Buy SignalOct 28, 9:50 AM3 days ago
SMA: BearishOct 28, 9:30 AM3 days ago
SMA: BearishOct 28, 9:30 AM3 days ago
MACD: Sell SignalOct 28, 9:30 AM3 days ago
RSI: OversoldOct 28, 9:30 AM3 days ago
SMA: BullishOct 27, 3:15 PM4 days ago
MACD: Buy SignalOct 27, 3:15 PM4 days ago
SMA: BullishOct 27, 3:10 PM4 days ago
MACD: Sell SignalOct 27, 2:30 PM4 days ago
SMA: BullishOct 27, 2:00 PM4 days ago
SMA: BullishOct 27, 2:00 PM4 days ago
MACD: Buy SignalOct 27, 2:00 PM4 days ago
MACD: Sell SignalOct 27, 1:50 PM4 days ago
SMA: BearishOct 27, 1:40 PM4 days ago
MACD: Buy SignalOct 27, 1:25 PM4 days ago
SMA: BearishOct 27, 12:40 PM4 days ago
SMA: BullishOct 27, 12:35 PM4 days ago
MACD: Sell SignalOct 27, 11:40 AM4 days ago
SMA: BearishOct 27, 11:20 AM4 days ago
SMA: BullishOct 27, 10:30 AM4 days ago
SMA: BearishOct 27, 10:15 AM4 days ago
SMA: BullishOct 27, 10:10 AM4 days ago
MACD: Buy SignalOct 27, 10:10 AM4 days ago
SMA: BullishOct 27, 10:05 AM4 days ago
SMA: BearishOct 27, 10:00 AM4 days ago
SMA: BullishOct 27, 9:55 AM4 days ago
SMA: BearishOct 27, 9:30 AM4 days ago
SMA: BearishOct 27, 9:30 AM4 days ago
MACD: Sell SignalOct 27, 9:30 AM4 days ago
RSI: OversoldOct 27, 9:30 AM4 days ago
SMA: BullishOct 26, 3:55 PM5 days ago
SMA: BearishOct 26, 2:40 PM5 days ago
SMA: BearishOct 26, 1:40 PM5 days ago
SMA: BullishOct 26, 1:15 PM5 days ago
RSI: OversoldOct 26, 1:05 PM5 days ago
SMA: BearishOct 26, 12:20 PM5 days ago
SMA: BullishOct 26, 11:50 AM5 days ago
RSI: OversoldOct 26, 11:20 AM5 days ago
RSI: OversoldOct 26, 11:05 AM5 days ago

Key statistics

Market cap
173.87B
Enterprise value
222.78B
Trailing P/E
40.14
Forward P/E
10.58
PEG ratio
13.72
Price / sales
2.73
Price / book
2.04
EPS (TTM)
0.76
Beta
0.28
Dividend yield
5.74%
Payout ratio
226.32%
Profit margin
6.80%
Revenue (TTM)
63.70B
Revenue growth
2.60%
Free cash flow
12.49B
Total cash
11.70B
Total debt
63.48B
Return on equity
5.01%
Shares outstanding
5.70B
Short % of float
2.42%
50-day average
28.49
200-day average
26.77

Analyst view

Consensus: buy

Buy
Price target (mean) 29.26 -4.1% downside
Target (low)
25.00
Target (mean)
29.26
Target (high)
36.00
Ratings (0m) 28 9 buy · 17 hold · 2 sell
  • Strong buy1
  • Buy8
  • Hold17
  • Sell1
  • Strong sell1

Next earnings

Nov 3, 2026

Expected Nov 3, 2026. Consensus EPS estimate 0.72803.

Earnings history

Financials — quick view

All financials
PFE Revenue — quarterly 15.03B
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
PFE Net income — quarterly -247.00M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
PFE EPS — quarterly -0.04
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

PFE recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 3, 2026Sep 28, 20260.729———
Aug 4, 2026Jun 28, 20260.6820.77+0.09+12.90%
May 5, 2026Mar 29, 20260.7220.75+0.03+3.88%
Feb 3, 2026Dec 31, 20250.5670.66+0.09+16.40%
Nov 4, 2025Sep 28, 20250.6330.87+0.24+37.44%
Aug 5, 2025Jun 29, 20250.580.78+0.20+34.48%

Upgrades / downgrades

PFE analyst upgrades and downgrades
DateFirmActionFromTo
Oct 9, 2026JP MorganmainNeutralNeutral
Oct 8, 2026Cantor FitzgeraldmainNeutralNeutral
Oct 6, 2026ScotiabankmainSector OutperformSector Outperform
Sep 10, 2026HSBCmainHoldHold
Aug 7, 2026GuggenheimmainBuyBuy
Jul 13, 2026BMO CapitalmainOutperformOutperform

About Pfizer Inc.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Sector
Healthcare
Industry
Drug Manufacturers - General
Country
United States
Website
pfizer.com

News

Your note

Sign in to keep a note on PFE — it syncs with the Stock Master app.

Insider holders

PFE insider holders
InsiderRelationLatest transactionDateShares held
BLAYLOCK RONALD EDirectorPurchaseAug 4, 202671,688
BOSHOFF CHRISTOFFELOfficerStock Award(Grant)Feb 24, 2026162,088
BOURLA ALBERTChief Executive OfficerPurchaseAug 11, 2026435,555
BUCKLEY MORTIMER J.DirectorPurchaseAug 4, 202637,632
DAMICO JENNIFER B.OfficerSaleAug 4, 202628,611
FONSECA LIDIA PH.D.OfficerConversion of Exercise of derivative securityFeb 24, 202646,455

Institution ownership

PFE institution ownership
Holder% heldSharesValueReported
Blackrock Inc.9.29%529,670,43316.16BJun 29, 2026
Vanguard Capital Management LLC6.53%372,149,85211.35BJun 29, 2026
State Street Corporation5.39%307,090,8979.37BJun 29, 2026
Geode Capital Management, LLC2.37%135,275,7824.13BJun 29, 2026
Vanguard Portfolio Management LLC2.09%119,235,0303.64BJun 29, 2026
Fisher Asset Management, LLC1.91%109,067,2913.33BJun 29, 2026

Fund ownership

PFE fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.17%180,944,8985.52BJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.59%147,700,0664.51BJun 29, 2026
iShares Trust-iShares Core S&P 500 ETF1.33%75,946,8892.32BSep 29, 2026
Fidelity Concord Street Trust-Fidelity 500 Index Fund1.30%73,983,9032.26BAug 30, 2026
SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust1.24%70,581,6112.15BSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Value Index Fund0.95%54,248,0961.65BJun 29, 2026
Advertisement